High Cost Drugs: This audit program is designed to be conducted on-site on a claim-specific and/or project-based scope. The targeted facilities are chosen based on their contractual arrangement (cost plus language), claims volume and historical experience. The audit focuses on identifying all HCD billed under certain revenue codes to which the “cost plus” language applies. National Audit identifies a large amount of overcharges by reviewing the pharmacy invoice to validate the actual cost, the medication administration record, nursing notes, infusion notes, UB92, itemized bill, etc. Then, National Audit validates what the hospital billed and what was paid by the client and how this coincides with the contract language. National Audit also identifies savings by identifying those drugs that were not administered to the member.
Implantable Devices: This audit program is designed to be conducted either as a desk review or an on-site audit on a claim-specific basis. Implantable device audits can also be conducted as a facility-based, focused audit. The targeted facility is chosen based on their contractual arrangement (cost plus language), claims volume and historical experience. The audit focuses on identifying all implantable devices billed under certain revenue codes to which the “cost plus” language applies. National Audit identifies savings by reviewing the purchasing invoice, the physicians order, operative report, history and physical, UB92 and itemized bill. Then, National Audit validates what the hospital billed and what was paid by the client and how this coincides with the contract language. National Audit also reviews the medical record to determine if the implantable device was actually implanted and if all implant items were used.
Editor’s Note: www.nationalaudit.com.